Investor Presentation

Creation of value through strategic acquisitions Technology differentiation, potential for growth above historical, attractive margins, near term accretion Filtration Process Analytics Fluid Management R REPLIGEN 2x 2014 1.5x 2016 Refine TANGENX TECHNOLOGY 2017 SPECTRUM LABS.COM 8x $60M (Cumulative pro forma acquisition year revenues) 2019 C TECHNOLOGIES, INC. $26M 2020 Molding NMS ARTESYN® Engineered Technology $35M 2022 total franchise revenue reflects 2022 financial results as of Feb. 22, 2023 2021 polymem ... M&A 2022 ~$500M ... ~$54M BIOFLEX SOLUTIONS .. ~$50M 15

View entire presentation